About Aptorum Group
Aptorum Group is a company based in London (United Kingdom) founded in 2017 by Ian Huen.. The company has 1 employees as of December 31, 2024. Aptorum Group operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Biogen, among others.
- Headquarter London, United Kingdom
- Employees 1 as on 31 Dec, 2024
- Founders Ian Huen
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Aptorum Group Limited
-
Annual Revenue
$0-100as on Dec 31, 2024
-
Net Profit
$-4.27 M-51.09as on Dec 31, 2024
-
EBITDA
$-3.54 M62.32as on Dec 31, 2024
-
Latest Funding Round
$3 M (USD), Post-IPO
Dec 09, 2022
- Investors
-
Employee Count
1
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Aptorum Group
Aptorum Group is a publicly listed company on the NASDAQ with ticker symbol APM in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Funding Insights of Aptorum Group
- Total Funding Total Funding
- Total Rounds 1
- Last Round Post-IPO — $3.0M
-
First Round
First Round
(09 Dec 2022)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2022 | Amount | Post-IPO - Aptorum Group | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Aptorum Group
Aptorum Group has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Aenco. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Blockchain-based financial solutions for healthtech are provided.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Aptorum Group
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Aptorum Group
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Aptorum Group Comparisons
Competitors of Aptorum Group
Aptorum Group operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Biogen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Aptorum Group
Frequently Asked Questions about Aptorum Group
When was Aptorum Group founded?
Aptorum Group was founded in 2017 and raised its 1st funding round 5 years after it was founded.
Where is Aptorum Group located?
Aptorum Group is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Who is the current CEO of Aptorum Group?
Ian Huen is the current CEO of Aptorum Group. They have also founded this company.
How many employees does Aptorum Group have?
As of Dec 31, 2024, the latest employee count at Aptorum Group is 1.
What does Aptorum Group do?
Aptorum Group was founded in 2017 and is headquartered in London, United Kingdom. Operations focus on the biotechnology sector, where small molecular therapeutics are developed to address various disorders. The pipeline includes drug candidates such as SACT-1 for neuroblastoma, ALS-4 for staphylococcus infections, ALS-1 for influenza, ALS-2 for bacterial infections, NLS-1 for endometriosis, and additional compounds. Leadership is provided by founder and CEO Ian Huen.
Who are the top competitors of Aptorum Group?
Aptorum Group's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
Is Aptorum Group publicly traded?
Yes, Aptorum Group is publicly traded on NASDAQ under the ticker symbol APM.
Who are Aptorum Group's investors?
Aptorum Group has 1 investor. Key investors include Aenco.
What is Aptorum Group's ticker symbol?
The ticker symbol of Aptorum Group is APM on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.